Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 694

1.

mountainClimber Identifies Alternative Transcription Start and Polyadenylation Sites in RNA-Seq.

Cass AA, Xiao X.

Cell Syst. 2019 Sep 5. pii: S2405-4712(19)30268-6. doi: 10.1016/j.cels.2019.07.011. [Epub ahead of print]

PMID:
31542416
2.

The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative study.

Zimbudzi E, Lo C, Robinson T, Ranasinha S, Teede HJ, Usherwood T, Polkinghorne KR, Kerr PG, Fulcher G, Gallagher M, Jan S, Cass A, Walker R, Russell G, Johnson G, Zoungas S.

PLoS One. 2019 Jul 15;14(7):e0219685. doi: 10.1371/journal.pone.0219685. eCollection 2019.

3.

Deep evolutionary origin of limb and fin regeneration.

Darnet S, Dragalzew AC, Amaral DB, Sousa JF, Thompson AW, Cass AN, Lorena J, Pires ES, Costa CM, Sousa MP, Fröbisch NB, Oliveira G, Schneider PN, Davis MC, Braasch I, Schneider I.

Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15106-15115. doi: 10.1073/pnas.1900475116. Epub 2019 Jul 3.

PMID:
31270239
4.

Cost of dialysis therapies in rural and remote Australia - a micro-costing analysis.

Gorham G, Howard K, Zhao Y, Ahmed AMS, Lawton PD, Sajiv C, Majoni SW, Wood P, Conlon T, Signal S, Robinson SL, Brown S, Cass A.

BMC Nephrol. 2019 Jun 25;20(1):231. doi: 10.1186/s12882-019-1421-z.

5.

Aboriginal and Torres Strait Islander people's domains of wellbeing: A comprehensive literature review.

Butler TL, Anderson K, Garvey G, Cunningham J, Ratcliffe J, Tong A, Whop LJ, Cass A, Dickson M, Howard K.

Soc Sci Med. 2019 Jul;233:138-157. doi: 10.1016/j.socscimed.2019.06.004. Epub 2019 Jun 5. Review.

PMID:
31200269
6.

Acute kidney injury in Indigenous Australians: an unrecognised priority for action.

Cass A, Hughes JT.

Med J Aust. 2019 Jul;211(1):14-15. doi: 10.5694/mja2.50232. Epub 2019 Jun 10. No abstract available.

PMID:
31179541
7.

Polyfunctionalised Nanoparticles Bearing Robust Gadolinium Surface Units for High Relaxivity Performance in MRI.

Chabloz NG, Wenzel MN, Perry HL, Yoon IC, Molisso S, Stasiuk GJ, Elson DS, Cass AEG, Wilton-Ely JDET.

Chemistry. 2019 Aug 14;25(46):10895-10906. doi: 10.1002/chem.201901820. Epub 2019 Jul 17.

PMID:
31127668
8.

Impact of Supplemental Private Health Insurance on Dialysis and Outcomes.

Sriravindrarajah A, Kotwal SS, Sen S, McDonald S, Jardine M, Cass A, Gallagher M.

Intern Med J. 2019 May 20. doi: 10.1111/imj.14375. [Epub ahead of print]

PMID:
31111611
9.

HMG-CoA reductase inhibitors (statins) and acute kidney injury: A secondary analysis of renal study outcomes.

Wang AY, Trongtrakul K, Bellomo R, Li Q, Cass A, Gallagher M; RENAL Study Investigators and the ANZICS Clinical Trials Group.

Nephrology (Carlton). 2019 Sep;24(9):912-918. doi: 10.1111/nep.13597. Epub 2019 May 27.

PMID:
31058387
10.

Incident haemodialysis and outcomes in the Top End of Australia.

Hughes JT, Majoni SW, Barzi F, Harris TM, Signal S, Lowah G, Kapojos J, Abeyaratne A, Sundaram M, Goldrick P, Jones SL, McFarlane R, Campbell LT, Stephens D, Cass A.

Aust Health Rev. 2019 Apr 18. doi: 10.1071/AH18230. [Epub ahead of print]

PMID:
30995950
11.

Development of a Minimally Invasive Microneedle-Based Sensor for Continuous Monitoring of β-Lactam Antibiotic Concentrations in Vivo.

Gowers SAN, Freeman DME, Rawson TM, Rogers ML, Wilson RC, Holmes AH, Cass AE, O'Hare D.

ACS Sens. 2019 Apr 26;4(4):1072-1080. doi: 10.1021/acssensors.9b00288. Epub 2019 Apr 17.

PMID:
30950598
12.

Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.

Viecelli AK, Polkinghorne KR, Pascoe EM, Paul-Brent PA, Hawley CM, Badve SV, Cass A, Hooi LS, Kerr PG, Mori TA, Ong LM, Voss D, Johnson DW, Irish AB; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

PLoS One. 2019 Mar 26;14(3):e0213274. doi: 10.1371/journal.pone.0213274. eCollection 2019.

13.

Is hyperfiltration associated with higher urine albumin-to-creatinine ratio at follow up among Indigenous Australians? The eGFR follow-up study.

Ekinci EI, Barr ELM, Barzi F, Hughes JT, Lawton PD, Jones GRD, Hoy W, Cass A, Thomas M, Sinha A, Jerums G, O'Dea K, MacIsaac RJ, Maple-Brown LJ.

J Diabetes Complications. 2019 May;33(5):343-349. doi: 10.1016/j.jdiacomp.2019.02.005. Epub 2019 Feb 21.

PMID:
30904420
14.

Laparoscopic fluorescence image-guided photothermal therapy enhances cancer diagnosis and treatment.

Singh M, Nabavi E, Zhou Y, Gallina ME, Zhao H, Ruenraroengsak P, Porter AE, Ma D, Cass AEG, Hanna GB, Elson DS.

Nanotheranostics. 2019 Jan 29;3(1):89-102. doi: 10.7150/ntno.28585. eCollection 2019.

15.

Microneedle Array-Based Platforms for Future Theranostic Applications.

Howells O, Rajendran N, Mcintyre S, Amini-Asl S, Henri P, Liu Y, Guy O, Cass AEG, Morris MC, Sharma S.

Chembiochem. 2019 Sep 2;20(17):2198-2202. doi: 10.1002/cbic.201900112. Epub 2019 Jun 24.

PMID:
30897259
16.

Nanoneedle-Mediated Stimulation of Cell Mechanotransduction Machinery.

Hansel CS, Crowder SW, Cooper S, Gopal S, João Pardelha da Cruz M, de Oliveira Martins L, Keller D, Rothery S, Becce M, Cass AEG, Bakal C, Chiappini C, Stevens MM.

ACS Nano. 2019 Mar 26;13(3):2913-2926. doi: 10.1021/acsnano.8b06998. Epub 2019 Mar 4.

17.

Measuring luteinising hormone pulsatility with a robotic aptamer-enabled electrochemical reader.

Liang S, Kinghorn AB, Voliotis M, Prague JK, Veldhuis JD, Tsaneva-Atanasova K, McArdle CA, Li RHW, Cass AEG, Dhillo WS, Tanner JA.

Nat Commun. 2019 Feb 20;10(1):852. doi: 10.1038/s41467-019-08799-6.

18.

Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial.

Gray NA, Zuo L, Hong D, Smyth B, Jun M, De Zoysa J, Vo K, Howard K, Wang J, Lu C, Liu Z, Cass A, Perkovic V, Jardine M.

Nephrology (Carlton). 2019 Oct;24(10):1056-1063. doi: 10.1111/nep.13530. Epub 2019 Apr 29.

PMID:
30723975
19.

Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease.

Lo C, Zimbudzi E, Teede HJ, Kerr PG, Ranasinha S, Cass A, Fulcher G, Gallagher M, Polkinghorne KR, Russell G, Usherwood T, Walker R, Zoungas S.

J Diabetes Complications. 2019 Jan;33(1):63-68. doi: 10.1016/j.jdiacomp.2018.09.020. Epub 2018 Oct 12.

PMID:
30621853
20.

Wellbeing intervention for chronic kidney disease (WICKD): a randomised controlled trial study protocol.

Dingwall KM, Nagel T, Hughes JT, Kavanagh DJ, Cass A, Howard K, Sweet M, Brown S, Sajiv C, Majoni SW.

BMC Psychol. 2019 Jan 8;7(1):2. doi: 10.1186/s40359-018-0264-x.

21.

Incorporating indigenous knowledge in health services: a consumer partnership framework.

Kirkham R, Maple-Brown LJ, Freeman N, Beaton B, Lamilami R, Hausin M, Puruntatemeri AM, Wood P, Signal S, Majoni SW, Cass A, Hughes JT.

Public Health. 2018 Oct 24. pii: S0033-3506(18)30276-2. doi: 10.1016/j.puhe.2018.08.009. [Epub ahead of print]

PMID:
30528543
22.

Development of drug-loaded protein nanoparticles displaying enzymatically-conjugated DNA aptamers for cancer cell targeting.

Mie M, Matsumoto R, Mashimo Y, Cass AEG, Kobatake E.

Mol Biol Rep. 2019 Feb;46(1):261-269. doi: 10.1007/s11033-018-4467-2. Epub 2018 Nov 12.

PMID:
30421127
23.

Electric Single-Molecule Hybridization Detector for Short DNA Fragments.

Loh AYY, Burgess CH, Tanase DA, Ferrari G, McLachlan MA, Cass AEG, Albrecht T.

Anal Chem. 2018 Dec 4;90(23):14063-14071. doi: 10.1021/acs.analchem.8b04357. Epub 2018 Nov 15.

PMID:
30398852
24.

Sex and mortality in septic severe acute kidney injury.

O'Brien Z, Cass A, Cole L, Finfer S, Gallagher M, McArthur C, McGuiness S, Myburgh J, Bellomo R, Mårtensson J; RENAL Study Investigators and the Australian and New Zealand Intensive Care Clinical Trials Group.

J Crit Care. 2019 Feb;49:70-76. doi: 10.1016/j.jcrc.2018.10.017. Epub 2018 Oct 23.

PMID:
30388491
25.

Infusion reactions following administration of intravenous rolapitant at an academic medical center.

Cass AS, Odinet JS, Valgus JM, Crona DJ.

J Oncol Pharm Pract. 2019 Oct;25(7):1776-1783. doi: 10.1177/1078155218808084. Epub 2018 Oct 22.

PMID:
30348072
26.

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Lo C, Toyama T, Wang Y, Lin J, Hirakawa Y, Jun M, Cass A, Hawley CM, Pilmore H, Badve SV, Perkovic V, Zoungas S.

Cochrane Database Syst Rev. 2018 Sep 24;9:CD011798. doi: 10.1002/14651858.CD011798.pub2. Review.

27.

Disparity of access to kidney transplantation by Indigenous and non-Indigenous Australians.

Khanal N, Lawton PD, Cass A, McDonald SP.

Med J Aust. 2018 Sep 17;209(6):261-266. Erratum in: Med J Aust. 2018 Dec 10;209(11):475.

PMID:
30208818
28.

Microneedle-based biosensor for minimally-invasive lactate detection.

Bollella P, Sharma S, Cass AEG, Antiochia R.

Biosens Bioelectron. 2019 Jan 1;123:152-159. doi: 10.1016/j.bios.2018.08.010. Epub 2018 Aug 10.

PMID:
30177422
29.

Public acceptability of computer-controlled antibiotic management: An exploration of automated dosing and opportunities for implementation.

Rawson TM, Ming D, Gowers SA, Freeman DM, Herrero P, Georgiou P, Cass AE, O'Hare D, Holmes AH.

J Infect. 2019 Jan;78(1):75-86. doi: 10.1016/j.jinf.2018.08.005. Epub 2018 Aug 10.

30.

Can economic incentives increase the use of home dialysis?

Manns B, Agar JWM, Biyani M, Blake PG, Cass A, Culleton B, Kleophas W, Komenda P, Lobbedez T, MacRae J, Marshall MR, Scott-Douglas N, Srivastava V, Magner P.

Nephrol Dial Transplant. 2019 May 1;34(5):731-741. doi: 10.1093/ndt/gfy223.

PMID:
30010852
31.

Decolourization and biodegradation of azo dye methyl red by Rhodococcus strain UCC 0016.

Maniyam MN, Ibrahim AL, Cass AEG.

Environ Technol. 2018 Jun 28:1-15. doi: 10.1080/09593330.2018.1491634. [Epub ahead of print]

PMID:
29923786
32.

Impact of CKD on Household Income.

Morton RL, Schlackow I, Gray A, Emberson J, Herrington W, Staplin N, Reith C, Howard K, Landray MJ, Cass A, Baigent C, Mihaylova B; SHARP Collaborative Group.

Kidney Int Rep. 2017 Dec 23;3(3):610-618. doi: 10.1016/j.ekir.2017.12.008. eCollection 2018 May.

33.

Analysis of Opioid Use Following Curative Cancer Treatment at a Large Urban Safety-net Hospital.

Cass AS, Alese JT, Kim C, Curry MA, LaFollette JA, Chen Z, Alese OB.

Clin J Pain. 2018 Oct;34(10):885-889. doi: 10.1097/AJP.0000000000000612.

PMID:
29578885
34.

Gathering Perspectives - Finding Solutions for Chronic and End Stage Kidney Disease.

Hughes JT, Dembski L, Kerrigan V, Majoni SW, Lawton PD, Cass A.

Nephrology (Carlton). 2018 Feb;23 Suppl 1:5-13. doi: 10.1111/nep.13233. No abstract available.

PMID:
29436104
35.

Models of care for co-morbid diabetes and chronic kidney disease.

Lo C, Zimbudzi E, Teede H, Cass A, Fulcher G, Gallagher M, Kerr PG, Jan S, Johnson G, Mathew T, Polkinghorne K, Russell G, Usherwood T, Walker R, Zoungas S.

Nephrology (Carlton). 2018 Aug;23(8):711-717. doi: 10.1111/nep.13232. Review.

PMID:
29405503
36.

High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.

Barr ELM, Barzi F, Hughes JT, Jerums G, Hoy WE, O'Dea K, Jones GRD, Lawton PD, Brown ADH, Thomas M, Ekinci EI, Sinha A, Cass A, MacIsaac RJ, Maple-Brown LJ.

Diabetes Care. 2018 Apr;41(4):739-747. doi: 10.2337/dc17-1919. Epub 2018 Jan 24.

PMID:
29367427
37.

Trajectories of eGFR decline over a four year period in an Indigenous Australian population at high risk of CKD-the eGFR follow up study.

Barzi F, Jones GRD, Hughes JT, Lawton PD, Hoy W, O'Dea K, Jerums G, MacIsaac RJ, Cass A, Maple-Brown LJ.

Clin Biochem. 2018 Mar;53:58-64. doi: 10.1016/j.clinbiochem.2018.01.011.

PMID:
29366878
38.
39.

A systematic review of adherence in Indigenous Australians: an opportunity to improve chronic condition management.

de Dassel JL, Ralph AP, Cass A.

BMC Health Serv Res. 2017 Dec 27;17(1):845. doi: 10.1186/s12913-017-2794-y. Review.

40.

Cross-sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR Study.

Hughes JT, Maple-Brown LJ, Thomas M, Lawton PD, Sinha A, Cass A, Barzi F, Jones G, Jerums G, MacIsaac RJ, O'Dea K, Hoy WE.

Nephrology (Carlton). 2018 Jan;23(1):37-45. doi: 10.1111/nep.12956.

PMID:
29250918
41.

Delivering precision antimicrobial therapy through closed-loop control systems.

Rawson TM, O'Hare D, Herrero P, Sharma S, Moore LSP, de Barra E, Roberts JA, Gordon AC, Hope W, Georgiou P, Cass AEG, Holmes AH.

J Antimicrob Chemother. 2018 Apr 1;73(4):835-843. doi: 10.1093/jac/dkx458. Review.

42.

Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis.

Wang Y, Gallagher M, Li Q, Lo S, Cass A, Finfer S, Myburgh J, Bouman C, Faulhaber-Walter R, Kellum JA, Palevsky PM, Ronco C, Saudan P, Tolwani A, Bellomo R.

Nephrol Dial Transplant. 2018 Jun 1;33(6):1017-1024. doi: 10.1093/ndt/gfx308.

PMID:
29186517
43.

Higher versus Lower Continuous Renal Replacement Therapy Intensity in Critically ill Patients with Liver Dysfunction.

O'Brien Z, Cass A, Cole L, Finfer S, Gallagher M, McArthur C, McGuiness S, Myburgh J, Bellomo R, Mårtensson J; RENAL Study Investigators and the Australian and New Zealand Intensive Care Clinical Trials Group.

Blood Purif. 2018;45(1-3):36-43. doi: 10.1159/000480224. Epub 2017 Nov 22.

PMID:
29161684
44.

Single molecule multiplexed nanopore protein screening in human serum using aptamer modified DNA carriers.

Sze JYY, Ivanov AP, Cass AEG, Edel JB.

Nat Commun. 2017 Nov 16;8(1):1552. doi: 10.1038/s41467-017-01584-3.

45.

Low uptake of Aboriginal interpreters in healthcare: exploration of current use in Australia's Northern Territory.

Ralph AP, Lowell A, Murphy J, Dias T, Butler D, Spain B, Hughes JT, Campbell L, Bauert B, Salter C, Tune K, Cass A.

BMC Health Serv Res. 2017 Nov 15;17(1):733. doi: 10.1186/s12913-017-2689-y.

46.

Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.

Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, Conner TA, Chertow GM, Bhatt DL, Shunk K, Parikh CR, McFalls EO, Brophy M, Ferguson R, Wu H, Androsenko M, Myles J, Kaufman J, Palevsky PM; PRESERVE Trial Group.

N Engl J Med. 2018 Feb 15;378(7):603-614. doi: 10.1056/NEJMoa1710933. Epub 2017 Nov 12.

47.

Chronic kidney disease and socio-economic status: a cross sectional study.

Ritte RE, Lawton P, Hughes JT, Barzi F, Brown A, Mills P, Hoy W, O'Dea K, Cass A, Maple-Brown L.

Ethn Health. 2017 Oct 31:1-17. doi: 10.1080/13557858.2017.1395814. [Epub ahead of print]

PMID:
29088917
48.

Gold nanorod reshaping in vitro and in vivo using a continuous wave laser.

Harris-Birtill D, Singh M, Zhou Y, Shah A, Ruenraroengsak P, Gallina ME, Hanna GB, Cass AEG, Porter AE, Bamber J, Elson DS.

PLoS One. 2017 Oct 18;12(10):e0185990. doi: 10.1371/journal.pone.0185990. eCollection 2017.

49.

Enhanced cyanide biodegradation by immobilized crude extract of Rhodococcus UKMP-5M.

Maniyam MN, Ibrahim AL, Cass AEG.

Environ Technol. 2019 Jan;40(3):386-398. doi: 10.1080/09593330.2017.1393015. Epub 2017 Oct 31.

PMID:
29032742
50.

Difficult conversations: Australian Indigenous patients' views on kidney transplantation.

Devitt J, Anderson K, Cunningham J, Preece C, Snelling P, Cass A.

BMC Nephrol. 2017 Oct 11;18(1):310. doi: 10.1186/s12882-017-0726-z.

Supplemental Content

Support Center